The plant, expected to begin operations by end-2024, will help develop Malaysia’s medical devices ecosystem through the supply of innovative flexible packaging solutions for Asia-Pacific’s rapidly growing healthcare industry.
This strategic investment marks a significant milestone in Mikart's commitment to enhancing its production capabilities and delivering high-quality pharmaceutical products.
The same government that destroyed Puerto Rico’s economy and the domestic pharmaceutical industry by repealing Section 936 in 2006 is now going to tell you what heroes they are by reviving that industry. It might be easier said than done.
